SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-23-001531
Filing Date
2023-08-11
Accepted
2023-08-11 16:16:40
Documents
51
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bdpt_10q.htm   iXBRL 10-Q 610609
2 CERTIFICATION bdpt_ex311.htm EX-31.1 12516
3 CERTIFICATION bdpt_ex312.htm EX-31.2 9167
4 CERTIFICATION bdpt_ex321.htm EX-32.1 4074
5 CERTIFICATION bdpt_ex322.htm EX-32.2 4099
11 bdpt_10qimg1.jpg GRAPHIC 3811
  Complete submission text file 0001640334-23-001531.txt   3004286

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bdpt-20230630.xsd EX-101.SCH 28038
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdpt-20230630_lab.xml EX-101.LAB 171661
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bdpt-20230630_cal.xml EX-101.CAL 32185
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdpt-20230630_pre.xml EX-101.PRE 144248
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bdpt-20230630_def.xml EX-101.DEF 78455
45 EXTRACTED XBRL INSTANCE DOCUMENT bdpt_10q_htm.xml XML 417630
Mailing Address 2620 REGATTA DRIVE SUITE 102 LAS VEGAS NV 89128
Business Address 2620 REGATTA DRIVE SUITE 102 LAS VEGAS NV 89128 (702) 659-8829
BIOADAPTIVES, INC. (Filer) CIK: 0001575142 (see all company filings)

IRS No.: 462592228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54949 | Film No.: 231164348
SIC: 2834 Pharmaceutical Preparations